Magenta Therapeutics, Inc. (MGTA) financial statements (2021 and earlier)

Company profile

Business Address 100 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments146143
Cash and cash equivalents6558
Short-term investments8184
Other undisclosed current assets43
Total current assets:150145
Noncurrent Assets
Property, plant and equipment1010
Restricted cash and investments22
Total noncurrent assets:1212
TOTAL ASSETS:162157
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1410
Accounts payable33
Accrued liabilities117
Total current liabilities:1410
Noncurrent Liabilities
Liabilities, other than long-term debt6 
Deferred rent credit6 
Other undisclosed noncurrent liabilities 1
Total noncurrent liabilities:61
Total liabilities:2012
Stockholders' equity
Stockholders' equity attributable to parent141146
Common stock00
Additional paid in capital321248
Accumulated other comprehensive income (loss)0(0)
Accumulated deficit(179)(103)
Total stockholders' equity:141146
TOTAL LIABILITIES AND EQUITY:162157

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Operating expenses(83)(60)
Operating loss:(83)(60)
Nonoperating income12
Investment income, nonoperating10
Loss before gain (loss) on sale of properties:(82)(58)
Other undisclosed net income5 
Net loss attributable to parent:(77)(58)
Preferred stock dividends and other adjustments (0)
Net loss available to common stockholders, diluted:(77)(58)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(77)(58)
Comprehensive loss:(77)(58)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)
Comprehensive loss, net of tax, attributable to parent:(77)(58)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: